Search Results - "SARUTA, Takao"

Refine Results
  1. 1

    Features of and preventive measures against hypertension in the young by Kawabe, Hiroshi, Azegami, Tatsuhiko, Takeda, Ayano, Kanda, Takeshi, Saito, Ikuo, Saruta, Takao, Hirose, Hiroshi

    Published in Hypertension research (01-07-2019)
    “…The Japanese hypertension guidelines report that essential hypertension is detected in 1-3% of upper elementary and high school students during blood pressure…”
    Get full text
    Journal Article
  2. 2

    Importance of rostral ventrolateral medulla neurons in determining efferent sympathetic nerve activity and blood pressure by Kumagai, Hiroo, Oshima, Naoki, Matsuura, Tomokazu, Iigaya, Kamon, Imai, Masaki, Onimaru, Hiroshi, Sakata, Katsufumi, Osaka, Motohisa, Onami, Toshiko, Takimoto, Chie, Kamayachi, Tadashi, Itoh, Hiroshi, Saruta, Takao

    Published in Hypertension research (01-02-2012)
    “…Accentuated sympathetic nerve activity (SNA) is a risk factor for cardiovascular events. In this review, we investigate our working hypothesis that potentiated…”
    Get full text
    Journal Article
  3. 3

    Ca2+ Channel Subtypes and Pharmacology in the Kidney by Hayashi, Koichi, Wakino, Shu, Sugano, Naoki, Ozawa, Yuri, Homma, Koichiro, Saruta, Takao

    Published in Circulation research (16-02-2007)
    “…A large body of evidence has accrued indicating that voltage-gated Ca channel subtypes, including L-, T-, N-, and P/Q-type, are present within renal vascular…”
    Get full text
    Journal Article
  4. 4

    Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial by Umemoto, Seiji, Ogihara, Toshio, Matsuzaki, Masunori, Rakugi, Hiromi, Ohashi, Yasuo, Saruta, Takao

    Published in Hypertension research (01-01-2016)
    “…Visit-to-visit blood pressure (BP) variability is an important predictor of stroke. However, which antihypertensive drug combination is better at reducing…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial by Umemoto, Seiji, Ogihara, Toshio, Matsuzaki, Masunori, Rakugi, Hiromi, Ohashi, Yasuo, Saruta, Takao

    Published in Hypertension research (01-04-2017)
    “…We compared three benidipine-based regimens-that is, benidipine plus angiotensin receptor blocker (ARB), β-blocker (BB) or thiazide-and found that the…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Correlation between Serum Resistin Level and Adiposity in Obese Individuals by Azuma, Koichiro, Katsukawa, Fuminori, Oguchi, Shuji, Murata, Mitsuru, Yamazaki, Hajime, Shimada, Akira, Saruta, Takao

    Published in Obesity (Silver Spring, Md.) (01-08-2003)
    “…Objective: Resistin is associated with insulin resistance in mice and may play a similar role in humans. The aim of our study was to examine the relationship…”
    Get full text
    Journal Article
  14. 14

    Adiponectin, an Adipocyte-Derived Protein, Predicts Future Insulin Resistance: Two-Year Follow-Up Study in Japanese Population by Yamamoto, Yukihiro, Hirose, Hiroshi, Saito, Ikuo, Nishikai, Kanako, Saruta, Takao

    “…It has been reported that the serum adiponectin level was negatively correlated with body mass index (BMI), insulin resistance index, and triglycerides and was…”
    Get full text
    Journal Article
  15. 15

    Aldosterone-Induced Organ Damage: Plasma Aldosterone Level and Inappropriate Salt Status by SATO, Atsuhisa, SARUTA, Takao

    Published in Hypertension Research (01-05-2004)
    “…In recent years, it has been clarified that aldosterone can directly damage various organs, such as the heart, blood vessel, and kidneys, via non-epithelial…”
    Get full text
    Journal Article
  16. 16

    Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial by Nakao, Kazuwa, Hirata, Masakazu, Oba, Koji, Yasuno, Shinji, Ueshima, Kenji, Fujimoto, Akira, Ogihara, Toshio, Saruta, Takao

    Published in Hypertension research (01-06-2010)
    “…The Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial assessed cardiovascular outcomes in high-risk hypertensive patients receiving…”
    Get full text
    Journal Article
  17. 17

    Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J Study by Saruta, Takao, Hayashi, Koichi, Ogihara, Toshio, Nakao, Kazuwa, Fukui, Tsuguya, Fukiyama, Kohshiro

    Published in Hypertension research (01-06-2009)
    “…We examined the effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease (CKD) using the data from…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability by Saruta, Takao, Ogihara, Toshio, Saito, Ikuo, Rakugi, Hiromi, Shimamoto, Kazuaki, Matsuoka, Hiroaki, Teramukai, Satoshi, Higaki, Jitsuo, Ito, Sadayoshi, Shimada, Kazuyuki

    Published in Hypertension research (01-02-2015)
    “…The cardiovascular effects of combined therapy with the angiotensin receptor blocker (olmesartan) and a dihydropyridine calcium channel blocker (CCB) or a…”
    Get full text
    Journal Article
  20. 20

    Pioglitazone Lowers Systemic Asymmetric Dimethylarginine by Inducing Dimethylarginine Dimethylaminohydrolase in Rats by Wakino, Shu, Hayashi, Koichi, Tatematsu, Satoru, Hasegawa, Kazuhiro, Takamatsu, Ichiro, Kanda, Takeshi, Homma, Koichiro, Yoshioka, Kyoko, Sugano, Naoki, Saruta, Takao

    Published in Hypertension research (01-03-2005)
    “…Peroxisome proliferator activated receptor-gamma (PPARgamma) ligands increase nitric oxide (NO) production and reduce systemic blood pressure. Asymmetric…”
    Get full text
    Journal Article